HBB and sickle cell disease: Consistent with our findings, Memish et al. (2011) reported a prevalence of 6.3% for beta-globin chain variations in a study involving 1,572,140 individuals from 2004 to 2009, with sickle cell disease and β-thalassemia affecting 4.5% and 1.8% of the population, respectively [13].